Question · asked by 1 review

Non-specific immunotherapy (recombinant interleukin-2 or BCG cell wall preparation) plus standard therapy vs Standard therapy alone (radiotherapy or chemoradiotherapy): Disease-free survival

Population
People with squamous cell carcinoma of the oral cavity or oropharynx
Intervention
Non-specific immunotherapy (recombinant interleukin-2 or BCG cell wall preparation) plus standard therapy
Comparison
Standard therapy alone (radiotherapy or chemoradiotherapy)
Outcome
Disease-free survival

It is very uncertain whether non-specific immunotherapy (recombinant interleukin-2 or BCG cell… changes disease-free survival compared with standard therapy alone (very low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Non-specific immunotherapy (recombinant interleukin-2 or BCG cell wall preparation) plus standard therapy vs Standard therapy alone
Disease-free survival · People with squamous cell carcinoma of the oral cavity or oropharynx · 24 to 70 months, Recombinant interleukin-2 + surgery (De Stefani 2002)
It is very uncertain whether non-specific immunotherapy (recombinant interleukin-2 or BCG cell… changes disease-free survival compared with standard therapy alone (very low certainty).
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy (2015) · Cochrane All outcomes
HR 0.66 [0.43, 1.02]1 study · 201 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy
2015 · Cochrane All outcomes
2015-02Not listedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.